Verve Therapeutics Inc
Biotechnology
Healthcare
VERV
88.80 M shares
NASDAQ US
traded
24 Jul 2025
listed
no
open
11.14
52 week high
11.38
high
11.25
52 week low
0.00
previous Close
11.10
P/E ratio
market cap
1.01 B
div yield
0
net profit margin
0.00 %
94.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top